Protillion Biosciences
Biotechnology company exploring therapeutic protein libraries at unprecedented scale using its proprietary platform to discover and develop novel protein-based medicines.
Website
https://www.protillion.comLocation
Cambridge, Massachusetts, USA
Founded
2021
Investors
1
Categories
biotech, protein-engineering, therapeutics, drug-discovery
Notes
Protillion Biosciences is a biotechnology company that explores therapeutic protein libraries like never before. The company's proprietary platform enables the screening and optimization of proteins at unprecedented scale, accelerating the discovery of novel protein-based therapeutics.
Protillion's approach allows for the exploration of vast protein sequence space to identify candidates with optimal therapeutic properties.
Team
- Leadership team with expertise in protein engineering and drug discovery
Additional Research Findings
- Founded in 2021 in Cambridge, Massachusetts
- Proprietary high-throughput protein screening platform
- Focus on therapeutic protein discovery and optimization
- Enables exploration of large protein libraries
- Applications in developing novel protein-based drugs
- Part of growing protein engineering/biologics space
- Cambridge biotech ecosystem company
Sources
Investors
| Name | Location | Type | Stages | Portfolio |
|---|---|---|---|---|
| Illumina Ventures | San Francisco, California, USA | biotech-focused | seedseries-a+1 | 32 |